Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LHDXQ |
---|---|---|
09:32 ET | 2920 | 0.078 |
09:34 ET | 2500 | 0.066 |
09:41 ET | 1000 | 0.065 |
09:54 ET | 2424 | 0.065 |
09:59 ET | 16351 | 0.0695 |
10:03 ET | 5132 | 0.069 |
10:12 ET | 100 | 0.069 |
10:28 ET | 100 | 0.0746 |
10:30 ET | 980 | 0.07 |
11:06 ET | 550 | 0.075 |
11:11 ET | 30000 | 0.075 |
11:15 ET | 2600 | 0.075 |
11:22 ET | 29450 | 0.071 |
11:24 ET | 22993 | 0.07 |
11:26 ET | 42500 | 0.066 |
11:27 ET | 22600 | 0.056 |
11:29 ET | 5000 | 0.056 |
11:31 ET | 100 | 0.0616 |
11:38 ET | 28411 | 0.072 |
11:42 ET | 5000 | 0.056 |
11:45 ET | 5000 | 0.072 |
11:51 ET | 11000 | 0.069 |
12:05 ET | 155 | 0.065 |
12:07 ET | 1000 | 0.056 |
12:30 ET | 235 | 0.0625 |
12:34 ET | 2000 | 0.0625 |
12:38 ET | 2089 | 0.065 |
01:01 ET | 18270 | 0.069 |
01:03 ET | 1000 | 0.069 |
01:15 ET | 16896 | 0.07 |
01:19 ET | 5000 | 0.056 |
01:35 ET | 2980 | 0.058 |
01:37 ET | 1000 | 0.05775 |
01:39 ET | 1000 | 0.058 |
02:00 ET | 4000 | 0.0575 |
02:02 ET | 160 | 0.058 |
02:24 ET | 1000 | 0.0699 |
02:40 ET | 40000 | 0.07 |
02:42 ET | 7500 | 0.06 |
02:45 ET | 40155 | 0.06 |
02:56 ET | 700 | 0.06 |
02:58 ET | 36100 | 0.055 |
03:02 ET | 9005 | 0.0604 |
03:03 ET | 5000 | 0.055 |
03:05 ET | 5000 | 0.0629 |
03:23 ET | 9339 | 0.06 |
03:27 ET | 7990 | 0.05725 |
03:41 ET | 5000 | 0.055 |
03:50 ET | 50000 | 0.0575 |
03:54 ET | 5100 | 0.0581 |
03:56 ET | 22550 | 0.05975 |
03:57 ET | 111 | 0.062 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Lucira Health Inc | 3.4M | 0.0x | --- |
Surgalign Holdings Inc | 7.0M | -0.1x | --- |
Sientra Inc | 18.4M | -0.2x | --- |
Retractable Technologies Inc | 31.1M | -20.1x | --- |
Conformis Inc | 8.2M | -0.2x | --- |
Trinity Biotech PLC | 34.5M | -0.6x | --- |
Lucira Health, Inc. is a medical technology company. The Company is focused on providing disposable, single use test kit platform to replace central lab testing for diagnosing infectious diseases which leads to treatment and disease control outcomes. The Company has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. It is also engaged in the commercialization of commercializing its PCR-quality COVID-19 test kits. Through its polymerase chain reaction (PCR)-quality technology, the Company offers single-use testing for infectious diseases. Its test kits are coupled with its digital platform, LUCI PASS, which is designed to securely deliver a clinically relevant test result to users at home, healthcare providers, and to required public health authorities. The Company has its operations in United States and Canada, among others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4M |
---|---|
Revenue (TTM) | $212.1M |
Shares Outstanding | 40.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.59 |
Book Value | $4.76 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -66.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.